Est. 2001·3,000+ placements · six offices · four regions
Partnershipcurated sourcedetected 2026-07-21 · confidence 90%

Last updated

Macmillan: Partnership

Macmillan and ORCHA launched a digital health app library to help cancer patients assess and access apps for care support.

Source: Digital Health

What happened
Macmillan and ORCHA launched a digital health app library to help cancer patients assess and access apps for care support.
Who
Macmillan · UK
When
2026-07-21
So what
The Macmillan-ORCHA partnership commits Macmillan to a structured, ongoing curation and governance function it did not formally hold before.

The leadership read

The Macmillan-ORCHA partnership commits Macmillan to a structured, ongoing curation and governance function it did not formally hold before. Publishing an app library is not a one-time act: it creates a live obligation to assess new entrants, delist products that fail safety or efficacy standards, and maintain clinical credibility as the app market shifts. That is a materially different operational posture than producing patient information content, and it puts Macmillan in a quasi-regulatory position relative to digital health vendors competing for patient trust. The related signals available here are thin on direct comparables. Of the 12 partnership signals tracked in the same period, none sits clearly in digital health or patient-facing clinical services; the closest adjacency is Elephas Biosciences partnering with Neuberg Diagnostics on personalised oncology access in India. The honest read is that this sits in a relatively early cluster of charity-sector organisations partnering with app-assessment platforms to create curated patient-facing libraries, rather than a dense wave with many named precedents. Where the pattern does surface functional demand, it concentrates at the intersection of clinical governance and digital product: organisations building validated digital health resources face rising pressure for leadership able to bridge NHS and regulatory standards, patient engagement, and vendor assessment. Commercial and partnerships capability that can manage health-tech suppliers under clinical rather than purely commercial criteria is the skill area this kind of activity consistently surfaces.

Market context: MitchelLake's Talent Market Index sits at 122.7 (Hot), up 17.8 on the prior month; EMEA hiring signal is running easing (-17.7pts).

Macmillan: 0 signals in the last 90 days.

MitchelLake in this thematic

More signals across EMEA

Partnership · EMEA

ClearSpace UK →

UK Space Agency selected ClearSpace UK to lead its Active Debris Removal Mission, backed by more than £60 million in UK government funding. The mission would remove two UK-registered satellites from Low Earth Orbit, with clean-up starting in 2029 and disposal completed by 2032.

Partnership · EMEA

Solana Mobile →

Solana Mobile announced Ledger as its first external hardware partner, bringing its Seeker application and Solana dApp Store access to Ledger's upcoming Atom security device. The announcement was made at Ledger's October event in Paris.

Partnership · EMEA

ORIC Pharmaceuticals →

ORIC Pharmaceuticals signed a collaboration with Cancer Research UK to move its CIP2A-targeted candidate ORIC-259 into early clinical development, with Cancer Research UK funding and running the initial studies.

Partnership · EMEA

Nel →

Norway-based Nel signed a Memorandum of Understanding with Rheinmetall AG to explore joint decentralised renewable fuel production, combining Nel electrolysers with Rheinmetall's Giga PtX concept for modular low-carbon synthetic fuels aimed at defence and critical infrastructure.

Partnership · EMEA

ITM Power →

UK-based ITM Power, via its build-own-operate subsidiary Hydropulse, signed Heads of Terms with a European oil refinery for a 150 MW green hydrogen project using ITM's Alpha electrolyser platform under a 10-year agreement. Parties target FID in 2027 with production from 2029.

Partnership · EMEA

STX Group →

Amsterdam-headquartered commodity trader STX Group took its first offtake of RFNBO-compliant e-methane produced by Turn2X at its first commercial plant in Spain, with first delivery in early October 2026 and active talks on future commercial-scale e-methane projects.

Where this lands in our work

Weekly briefing

Track companies like Macmillan — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗